Oliver Aregullin, MD, FAAP, FSCAI
- Cardiology
Pediatric and Adult Congenital Interventional Cardiologist
Medical Director, Cardiac Catheterization Laboratory, Austin
Clinical Associate Professor, Baylor College of Medicine
Phone:
737-220-8200
Languages: English, Spanish
Office locations:
9835 North Lake Creek Parkway
Austin, TX 78717
Get to know Oliver Aregullin, MD, FAAP, FSCAI
Dr. Oliver Aregullin is a Pediatric and Adult Congenital Interventional Cardiologist who specializes in cardiac catheterization procedures for babies, children and adults with congenital heart disease. He delivers advanced and personalized care for patients with complex cardiac conditions, using the most advanced cardiac catheter technology. Dr. Aregullin has previously developed a dedicated Pediatric Hypertension and Congenital Cardiology Fellowship Program and has been instrumental in implementing new catheter technologies such as transcatheter pulmonary valve replacements and devices.
He is a longstanding advocate of family-centered decision-making, outcomes and transparency. He has contributed to more than 50 peer-review journal articles, numerous chapters and textbooks. Dr. Aregullin is a member of several academic and professional medical associations, including the American Board of Pediatrics, the American Board of Internal Medicine and The Society of Cardiovascular Angiography and Interventions.
Personal Statement
My daily goal is to treat my patients with the same time, dedication and devotion I would invest on my loved ones. I will put your best health interests first by using evidence-based practices and establishing a personal relation with you and your family.
Clinical Interests
Neonatal, pediatric and adult cardiac catheter interventions
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Nicklaus Children's Hospital | Fellowship | Pediatric Interventional Cardiology | 2016 |
| Nicklaus Children's Hospital | Fellowship | Pediatric Cardiology | 2014 |
| Nicklaus Children's Hospital | Residency | Pediatrics | 2011 |
| Universidad Autonoma de Nuevo Leon | Residency | Pediatrics | 2007 |
| Universidad Autonoma de Nuevo Leon | Medical School | Doctor of Medicine | 2004 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics | Fellow |
| American Board of Internal Medicine | Fellow |
| American Board of Pediatrics | Fellow |
| Pediatric and Congenital Interventional Cardiology Society | Fellow |
| Society Of Cardiovascular Angiography and Interventions | Fellow |
Board Certification
American Board of Pediatrics, FAAP
American Board of Internal Medicine
Honors and awards
- 2021
-
Teaching Award, Helen DeVos Children’s Hospital
- 2012-2014
-
Chief Cardiology Fellow, Miami Children’s Hospital
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Research interests
Utilization of minimal radiation and non-radiation technology for cardiac catheter interventions
Deniwar A, Hernandez J, Aregullin O, Khan SK, Huang S, Finn MT, Vettukattil JJ. Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure. Cardiology Young, 2023 Jul 19:1-6. doi: 10.1017/S104795112300152X. Online ahead of print. PMID: 37466020
Aregullin EO, Samuel BP, Girgis R, Vettukattil JJ. Emergency Use of Occlutech® Atrial Flow Regulator Device Facilitates Weaning From Veno-Arterial Extracorporeal Membrane Oxygenation in a Patient With Severe Pulmonary Arterial Hypertension. Journal of Intensive Care Medicine. 2021 Jun;36(6):726-728. doi: 10.1177/08850666211007809. Epub 2021 Apr 15. PMID: 33853402
Aregullin EO, Samuel B, Vettukattil J. Planned reduction in Fontan fenestration size using the Atrial Flow Regulator. Cardiology Young, 2021, Apr 12:1-3. doi: 10.1017/S104795112100127X. Epub ahead of print. PMID: 33843522
Diaz-Frias J, Mark PR, Aregullin EO. Two cases of different genetic variants of alveolar capillary dysplasia associated with left-sided obstructive CHDs. Cardiology Young, 2021 Mar 5:1-3. doi: 10.1017/S1047951121000676. Epub ahead of print. PMID: 33663630
Aregullin EO, Mohammad Nijres B, Al-Khatib Y, Vettukattil J. Transcatheter Fontan completion using novel balloon and stent system. Catheterization and Cardiovasc Interventions. 2021 Mar;97(4):679-684. doi: 10.1002/ccd.29463. Epub 2021 Jan 14. PMID: 33444467
Mohammad Nijres B, Aregullin EO, Al-Khatib Y, Samuel BP, Abdulla RI, Hijazi ZM, Vettukattil JJ. Aortopulmonary Collaterals in Single Ventricle Physiology: Variation in Understanding Occlusion Practice Among Interventional Cardiologists. Pediatric Cardiology. 2020 Dec;41(8):1608-1616. doi: 10.1007/s00246-020-02418-8. Epub 2020 Jul 27. PMID: 32720087
Kaley VR, Aregullin EO, Samuel BP, Vettukattil JJ. Trends in the off-label use of β-blockers in pediatric patients. Pediatrics International. 2019 Nov;61(11):1071-1080. doi: 10.1111/ped.14015. Epub 2019 Nov 12. PMID: 31571355
Huang, S., Aregullin, EO., Gosnell, J.M., Samuel, B.P., Kaley, V.R., Castiaux, A.D., Pinger, C.W., Apkinar, M.H., Chinnadurai, P., Spence, D.M., Contag, C.H., & Vettukattil, J.J. Rapid prototyping and image fusion guidance for transcatheter closure of superior sinus venosus atrial septal defect. SN Comprehensive Clinical Medicine, (2019), doi:10.1007/s42399-019-00169-z.
Aregullin EO, Kaley VR, Vettukattil JJ. Pulmonary arteriovenous malformations leading to hypoxemia in child with primary ciliary dyskinesia. Pediatric Pulmonology. 2019 Mar;54(3)